Who owns OLEMA PHARMACEUTICALS INC?
- Ticker: OLMA
- CUSIP Number: 68062p106
Tip: Access positions for across all investors
Analyze quarterly positions in Olema Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Olema Pharmaceuticals stock
Who bought or sold OLEMA PHARMACEUTICALS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
BVF | 9.1M | $109M | 0% | Sep 2024 |
|
Paradigm Biocapital Advisors | 5.5M | $66M | -30% | Sep 2024 |
|
Deep Track Capital | 4.0M | $43M | 24% | Jun 2024 |
|
BlackRock | 4.0M | $43M | 24% | Jun 2024 |
|
BlackRock | 3.8M | $46M | 100% | Sep 2024 |
|
Point72 Asset Management | 3.7M | $44M | 15% | Sep 2024 |
|
Logos Global Management | 3.2M | $35M | -27% | Jun 2024 |
|
Vanguard Group | 2.7M | $30M | 14% | Jun 2024 |
|
MPM Oncology Impact Management | 2.7M | $29M | 36% | Jun 2024 |
|
State Street Corporation | 1.9M | $21M | -39% | Jun 2024 |
|
Pictet Asset Management Holding SA | 1.7M | $20M | 100% | Sep 2024 |
|
Dimensional Fund Advisors | 1.4M | $16M | -18% | Sep 2024 |
|
Woodline Partners | 1.4M | $16M | 59% | Sep 2024 |
|
Citadel Advisors | 1.3M | $15M | 628% | Sep 2024 |
|
Candriam Luxembourg S.C.A. | 1.1M | $12M | 200% | Jun 2024 |
|
Dr. Jeffrey R. Jay, M.D. | 1.0M | $12M | 25% | Sep 2024 |
|
Geode Capital Management | 935k | $11M | -12% | Sep 2024 |
|
Victory Capital Management | 852k | $10M | 10% | Sep 2024 |
|
Boxer Capital | 650k | $7.8M | 0% | Sep 2024 |
|
Ghost Tree Capital | 550k | $6.0M | 175% | Jun 2024 |
|
Silverarc Capital Management | 547k | $5.9M | 6% | Jun 2024 |
|
Schonfeld Strategic Advisors | 462k | $5.5M | 295% | Sep 2024 |
|
Bank of America Corporation | 411k | $4.9M | 208% | Sep 2024 |
|
Goldman Sachs Group | 401k | $4.3M | -8% | Jun 2024 |
|
Northern Trust | 390k | $4.7M | 12% | Sep 2024 |
|
Morgan Stanley | 336k | $3.6M | -33% | Jun 2024 |
|
Charles Schwab Investment Management | 331k | $3.9M | 168% | Sep 2024 |
|
Marshall Wace | 240k | $2.9M | -59% | Sep 2024 |
|
Soleus Capital Management | 217k | $2.3M | -67% | Jun 2024 |
|
Alliancebernstein | 209k | $2.3M | 731% | Jun 2024 |
|
Two Sigma Investments | 182k | $2.0M | 90% | Jun 2024 |
|
Jpmorgan Chase & Co | 181k | $2.2M | 659% | Sep 2024 |
|
Schroder Investment Management Group | 160k | $1.7M | 100% | Jun 2024 |
|
Newtyn Management | 140k | $1.7M | 0% | Sep 2024 |
|
Bank of New York Mellon | 132k | $1.6M | -6% | Sep 2024 |
|
Two Sigma Advisers | 130k | $1.4M | -13% | Jun 2024 |
|
Susquehanna International | 124k | $1.5M | 7% | Sep 2024 |
|
Trexquant Investment | 120k | $1.4M | 5% | Sep 2024 |
|
Nuveen Asset Management | 118k | $1.3M | 17% | Jun 2024 |
|
Hennion & Walsh Asset Management | 118k | $1.4M | 35% | Sep 2024 |
|
Hrt Financial | 109k | $1.3M | 100% | Sep 2024 |
|
Barclays | 95k | $1.1M | 105% | Sep 2024 |
|
Ikarian Capital | 92k | $1.1M | 100% | Sep 2024 |
|
Rafferty Asset Management | 91k | $1.1M | -69% | Sep 2024 |
|
Dana Investment Advisors | 86k | $1.0M | 15% | Sep 2024 |
|
Jane Street | 79k | $945k | 50% | Sep 2024 |
|
Jacobs Levy Equity Management | 75k | $895k | -14% | Sep 2024 |
|
ExodusPoint Capital Management | 70k | $834k | 100% | Sep 2024 |
|
Swiss National Bank | 66k | $788k | 0% | Sep 2024 |
|
ClariVest Asset Management | 63k | $683k | 0% | Sep 2024 |
|
Jump Financial | 63k | $753k | 106% | Sep 2024 |
|
Caption Management | 60k | $718k | 100% | Sep 2024 |
|
Rhumbline Advisers | 58k | $691k | -2% | Sep 2024 |
|
Squarepoint Ops | 57k | $618k | -22% | Jun 2024 |
|
Henderson Group | 56k | $605k | -95% | Jun 2024 |
|
Ing Investment Management | 52k | $624k | 66% | Sep 2024 |
|
Envestnet Asset Management | 50k | $594k | 1% | Sep 2024 |
|
EP Wealth Advisors | 49k | $581k | 5% | Sep 2024 |
|
ALPS Advisors | 46k | $546k | 18% | Sep 2024 |
|
EntryPoint Capital | 35k | $413k | 100% | Sep 2024 |
|
Deerfield Management Company | 33k | $398k | 6% | Sep 2024 |
|
California State Teachers Retirement System | 32k | $384k | -3% | Sep 2024 |
|
T. Rowe Price Associates | 32k | $376k | 1% | Sep 2024 |
|
Citigroup | 30k | $360k | 27% | Sep 2024 |
|
Renaissance Technologies | 29k | $351k | -45% | Sep 2024 |
|
American Century Companies | 29k | $347k | 145% | Sep 2024 |
|
Deutsche Bank Aktiengesellschaft | 27k | $324k | -89% | Sep 2024 |
|
Susquehanna Portfolio Strategies | 27k | $287k | -23% | Jun 2024 |
|
D. E. Shaw & Co | 26k | $306k | 22% | Sep 2024 |
|
Mirae Asset Global Etfs Holdings | 26k | $311k | 51% | Sep 2024 |
|
Pitcairn Company | 25k | $293k | 100% | Sep 2024 |
|
MetLife Investment Advisors | 24k | $283k | 0% | Sep 2024 |
|
Royal Bank of Canada | 24k | $287k | 87% | Sep 2024 |
|
Corton Capital | 19k | $229k | 33% | Sep 2024 |
|
ProFund Advisors | 19k | $205k | -58% | Jun 2024 |
|
Ensign Peak Advisors | 19k | $225k | 27% | Sep 2024 |
|
Verition Fund Management | 19k | $201k | -85% | Jun 2024 |
|
Wells Fargo & Company | 17k | $200k | 3% | Sep 2024 |
|
Manufacturers Life Insurance Company | 16k | $172k | 52% | Jun 2024 |
|
Alpine Partners VI | 16k | $172k | 100% | Jun 2024 |
|
Invesco | 15k | $181k | -2% | Sep 2024 |
|
Franklin Resources | 15k | $177k | 0% | Sep 2024 |
|
Intech Investment Management | 14k | $163k | 100% | Sep 2024 |
|
SG Americas Securities | 13k | $156k | 100% | Sep 2024 |
|
Portland Investment Counsel | 12k | $143k | 100% | Sep 2024 |
|
China Universal Asset Management | 11k | $132k | 68% | Sep 2024 |
|
Conway Capital Management | 10k | $119k | 100% | Sep 2024 |
|
Zurcher Kantonalbank | 9.3k | $111k | 0% | Sep 2024 |
|
Tower Research Capital | 9.2k | $100k | 469% | Jun 2024 |
|
New York State Common Retirement Fund | 8.9k | $106k | -48% | Sep 2024 |
|
Summit Investment Advisors | 3.9k | $47k | 0% | Sep 2024 |
|
Mirae Asset Global Investments | 2.1k | $25k | 24% | Sep 2024 |
|
Federation des caisses Desjardins du Quebec | 2.0k | $24k | 100% | Sep 2024 |
|
Quest Partners | 1.9k | $23k | 100% | Sep 2024 |
|
Amundi | 1.8k | $21k | 100% | Sep 2024 |
|
Pnc Financial Services | 1.3k | $15k | -9% | Sep 2024 |
|
Nbc Securities | 1.2k | $14k | 0% | Sep 2024 |
|
CWM | 1.1k | $13k | 1% | Sep 2024 |
|
Russell Investments | 1.0k | $11k | 2651% | Jun 2024 |
|
Advisor Group Holdings | 943.00 | $11k | 169% | Sep 2024 |
|
Amalgamated Bank | 906.00 | $11k | 0% | Sep 2024 |
|
Umb Bank N A | 848.00 | $10k | -17% | Sep 2024 |
|
Huntington National Bank | 611.00 | $7.3k | -5% | Sep 2024 |
|
Wolff Wiese Magana | 600.00 | $7.2k | 0% | Sep 2024 |
|
Fortitude Family Office | 319.00 | $3.8k | 0% | Sep 2024 |
|
GAMMA Investing | 263.00 | $3.1k | 370% | Sep 2024 |
|
Daiwa Securities Group | 224.00 | $3.0k | 0% | Sep 2024 |
|
Signature | 162.00 | $1.9k | 0% | Sep 2024 |
|
Sterling Capital Management | 105.00 | $1.3k | 100% | Sep 2024 |
|
FTB Advisors | 87.00 | $1.0k | 0% | Sep 2024 |
|
NISA Investment Advisors | 74.00 | $883.996600 | 28% | Sep 2024 |
|
Rothschild Investment | 50.00 | $597.000000 | 400% | Sep 2024 |
|
Lindbrook Capital | 41.00 | $489.999200 | -74% | Sep 2024 |
|
Covestor | 7.00 | $0 | 0% | Sep 2024 |
|
Who sold out of Olema Pharmaceuticals?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Altium Capital Management | Mar 2024 | 605k | $6.8M |
Affinity Asset Advisors | Jun 2024 | 275k | $3.0M |
Exome Asset Management | Mar 2024 | 143k | $1.6M |
Connor, Clark & Lunn Investment Management | Jun 2024 | 28k | $305k |
Brevan Howard Capital Management | Jun 2024 | 22k | $242k |
Susquehanna Fundamental Investments | Mar 2024 | 16k | $176k |
E Fund Management | Mar 2024 | 14k | $158k |
J. Goldman & Co | Mar 2024 | 14k | $153k |
Cubist Systematic Strategies | Jun 2024 | 13k | $145k |
XTX Topco | Jun 2024 | 13k | $135k |
Bayesian Capital Management | Jun 2024 | 12k | $131k |
AQR Capital Management | Jun 2024 | 12k | $131k |
Pacer Advisors | Mar 2024 | 1.4k | $16k |
Truvestments Capital | Mar 2024 | 1.3k | $15k |
Simplex Trading | Jun 2024 | 736.00 | $7.0k |
Abich Financial Wealth Management | Jun 2024 | 10.00 | $108.000000 |